Left Anterior Descending Nonculprit Lesions and Clinical Outcomes in Patients With ST-Segment Elevation Myocardial Infarction
JACC: Cardiovascular Interventions · 2025-02 · 18 (3) · 297-307
DOI: 10.1016/j.jcin.2024.09.004 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JACC: Cardiovascular Interventions, 2025-02. Verfasst von Brian P McGrath und 22 weiteren Autor:innen. Beteiligte Einrichtung: Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada. Hauptthemen laut MEDLINE: ST Elevation Myocardial Infarction, Percutaneous Coronary Intervention, Coronary Artery Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: AstraZeneca Canada Inc, Boston Scientific Corporation, Canadian Institutes of Health Research.
Abstract (Originalsprache)
BACKGROUND: In the COMPLETE (Complete vs Culprit-Only Revascularization to Treat Multi-Vessel Disease After Early PCI for STEMI) trial, complete revascularization in patients with ST-segment elevation myocardial infarction (STEMI) and multivessel disease (MVD) reduced important outcomes compared with culprit-only percutaneous coronary intervention. Whether clinical outcomes in STEMI patients with MVD are influenced by the presence of a left anterior descending (LAD) nonculprit lesion (NCL) remains unknown. OBJECTIVES: This study sought to compare: 1) cardiovascular outcomes among patients with an NCL in the proximal/mid-LAD to patients with an NCL in other locations; and 2) the benefit of NCL revascularization in patients with and without a proximal/mid-LAD NCL. METHODS: The COMPLETE trial enrolled patients presenting with STEMI and MVD to angiography-guided complete revascularization vs a culprit lesion-only strategy. All coronary angiograms were evaluated in a central core laboratory. In this prespecified subanalysis, treatment effect according to proximal/mid-NCL location was determined for the coprimary outcomes of: 1) cardiovascular death or new myocardial infarction; and 2) cardiovascular death, new myocardial infarction, or ischemia-driven revascularization. Cox proportional hazards models were performed with an interaction term for treatment allocation and NCL location. RESULTS: Of the 4,041 subjects in COMPLETE, 1,666 patients had a proximal/mid-LAD NCL (41.2%). The first coprimary outcome occurred in 8.5% (2.9%/y) of patients with a proximal/mid-LAD NCL vs 9.9% (3.4%/y) in those without (adjusted HR: 0.83; 95% CI: 0.67-1.03). Complete revascularization had a similar benefit in reducing the first coprimary outcome for patients with a proximal/mid-LAD NCL (7.7% vs 9.2%; HR: 0.85; 95% CI: 0.61-1.18) and those without (8.0% vs 11.9%; HR: 0.65; 95% CI: 0.50-0.86), with no differential treatment effect (interaction P = 0.235) CONCLUSIONS: Among patients presenting with STEMI and multivessel CAD, those with a proximal/mid-LAD NCL had similar event rates to those without. The benefit of complete revascularization between the groups was similar, with no evidence of heterogeneity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, Ontario, Canada.
- Centre for Cardiovascular Innovation, University of British Columbia, Vancouver, British Columbia, Canada.
- Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada.
- Hôpital du Sacré-Coeur de Montréal, Université de Montréal, Montreal, Quebec, Canada.
- Montreal Heart Institute and Université de Montréal, Montreal, Quebec, Canada.
- Peter Munk Cardiac Centre, University Health Network, Toronto, Ontario, Canada.
Förderung
- AstraZeneca Canada Inc
- Boston Scientific Corporation
- Canadian Institutes of Health Research
Zitieren
APA
McGrath, B. P., Pinilla-Echeverri, N., Wood, D. A., Bainey, K. R., Sheth, T., Schampaert, E., Tanguay, J. F., Džavík, V., Storey, R. F., Mehran, R., Bossard, M., Moreno, R., Campo, G., Rao, S. V., Cantor, W. J., Lavi, S., Johnston, P. V., Guiducci, V., Kim, H. H., …, & Mehta, S. R. (2025). Left Anterior Descending Nonculprit Lesions and Clinical Outcomes in Patients With ST-Segment Elevation Myocardial Infarction. JACC: Cardiovascular Interventions, 18(3), 297-307. https://doi.org/10.1016/j.jcin.2024.09.004
Vancouver
McGrath BP, Pinilla-Echeverri N, Wood DA, Bainey KR, Sheth T, Schampaert E, et al. Left Anterior Descending Nonculprit Lesions and Clinical Outcomes in Patients With ST-Segment Elevation Myocardial Infarction. JACC: Cardiovascular Interventions. 2025;18(3):297-307. doi:10.1016/j.jcin.2024.09.004
BibTeX
@article{McGrath2025,
author = {McGrath, Brian P and Pinilla-Echeverri, Natalia and Wood, David A and Bainey, Kevin R and Sheth, Tej and Schampaert, Erick and Tanguay, Jean-Francois and Džavík, Vladimír and Storey, Robert F and Mehran, Roxana and Bossard, Matthias and Moreno, Raul and Campo, Gianluca and Rao, Sunil V and Cantor, Warren J and Lavi, Shahar and Johnston, Peter V and Guiducci, Vincenzo and Kim, Hahn Hoe and Mani, Thenmozhi and Nguyen, Helen and Cairns, John A and Mehta, Shamir R},
title = {Left Anterior Descending Nonculprit Lesions and Clinical Outcomes in Patients With ST-Segment Elevation Myocardial Infarction},
journal = {JACC: Cardiovascular Interventions},
year = {2025},
volume = {18},
number = {3},
pages = {297--307},
doi = {10.1016/j.jcin.2024.09.004}
}
EUVIMED